The uPAR system is often considered a marker for aggressive disease, and men allocated to undergo curatively intended treatment are selected based on their favorable risk stratification and may not have a tumor burden leading to highly elevated uPAR levels. This evidence concerns the gene PLAUR and neoplasm.